341 results on '"Geleziunas Romas"'
Search Results
2. Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
3. HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection
4. Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants
5. Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
6. Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques
7. Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques
8. Long-acting capsid inhibitor protects macaques from repeat SHIV challenges
9. Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus
10. Lack of therapeutic efficacy of an antibody to α 4 β 7 in SIVmac251-infected rhesus macaques
11. Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals
12. Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates.
13. A Human Monoclonal Antibody Neutralizes Diverse HIV-1 Isolates by Binding a Critical gp41 Epitope
14. Covalent Stabilization of Coiled Coils of the HIV gp41 N Region Yields Extremely Potent and Broad Inhibitors of Viral Infection
15. HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection
16. Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation
17. Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
18. Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound
19. T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification
20. Blood biomarkers of expressed and inducible HIV-1
21. Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys
22. New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action
23. Catalytically-Active Complex of HIV-1 Integrase with a Viral DNA Substrate Binds Anti-Integrase Drugs
24. HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys
25. B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers
26. Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
27. Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
28. Long-acting capsid inhibitor protects macaques from repeat SHIV challenges
29. Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys
30. Affinities between the Binding Partners of the HIV-1 Integrase Dimer-Lens Epithelium-derived Growth Factor (IN Dimer-LEDGF) Complex
31. RAPID ESTABLISHMENT OF THE VIRAL RESERVOIR PRIOR TO SYSTEMIC VIREMIA FOLLOWING MUCOSAL SIV INFECTION OF RHESUS MONKEYS: O1.07
32. Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals
33. Evaluation of Broadly Neutralizing Antibody Sensitivity by Genotyping and Phenotyping for Qualifying Participants to HIV Clinical Trials
34. A Strategy for Selectively Shielding Portions of a Peptide/Protein from Immune Response while Maintaining Immunogenicity of Contiguous Epitopes
35. The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy
36. Identification of a Novel HIV-1 Neutralizing Antibody Using Synthetic Peptides that Mimic a GP41 Fusion Intermediate
37. Covalent Trimeric Coiled Coils of the HIV gp41 HR1 Region are Extremely Potent and Broadly Neutralizing Inhibitors of Viral Infection
38. CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification
39. TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption
40. The generation of nfkb2 p52: mechanism and efficiency
41. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell
42. Therapeutic vaccination of SIV-infected, ART-treated infant rhesus macaques using Ad48/MVA in combination with TLR-7 stimulation
43. Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus–1
44. Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia
45. Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41
46. Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay
47. The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection
48. Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor κB
49. Human Immunodeficiency Virus Type 1-Associated Cd4 Downmodulation
50. PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.